Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re:Not necessarily a bad thing Albie
I would say it would depend on the per share offer before I would have an opinion on whether it is good or bad. It certainly has the potential of of being quite disappointing to retail shareholders. Been there before with a buyout. It is not pretty and to think some sort of class action would get us "what's coming to us" in terms of the real value of the IP, think again. The lawyers get their end first and then a few pennies are left over for retail. Seen it happen dozens of times.
2
Jan 14, 2008 06:43AM
Share
New Message
Please login to post a reply